TPG Biotech previously invested $12.8 million in the Company, and along with the Company’s angel investors, has financed the Company since inception. The Company plans to use the
The allowed patent claims contain both composition and method of treatment claims that will broadly cover all of InSite’s bromfenac product candidates, including BromSite ((bromfenac 0.075%) ophthalmic solution
This partnership will launch the Aprecia brand, as well as provide comprehensive commercialization of Aprecia’s pioneering technology platform and initial pharmaceutical products. Aprecia is the first and only
The new collaboration agreement, designated OPeRA (Organ Protection & Replacement Institute), includes pre-clinical research and development programs as well as clinical phase II programs, providing NeuroVive with access
Terms of the acquisition were not disclosed, but include an investment in TrialScope by its investors of $5 million for technology development, sales and marketing in addition to
"I am pleased that our team has achieved this very important milestone, which also further strengthens our financial position," said Nancy Pecota, Chief Financial Officer, Aradigm. The Phase
The focus of the collaboration is the development of an effective therapy for GA using Foamix’s stable patented topical OilGel formulation containing minocycline, an antibiotic in the tetracycline
Using Medrio’s eClinical Software as a Service (SaaS) suite, bioskin is able to provide clients a user-friendly, efficient and cost-effective solution for data collection. "Our data managers are
The expansion includes significant incremental capacity to existing services, and will also provide Frontage with additional room for future growth. The renovation plan involves two phases. Initial enhancements,
AZD0914 is a novel oral antibiotic entering Phase II clinical trials to investigate efficacy in treating uncomplicated gonorrhoea and is the first of a novel class of molecules
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.